DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

Phase 3

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

First Posted Date: 2001-07-09

Last Posted Date: 2020-12-02

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 165

Registration Number: NCT00018863

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
🇺🇸
New York University School of Medicine, New York, New York, United States
🇺🇸
University of California, Irvine, Irvine, California, United States

and more 3 locations

Treatment of Behavioral Symptoms in Alzheimer's Disease

Phase 4

Completed

Conditions: Agitation
Psychosis
Alzheimer's Disease

Interventions: Drug: Haloperidol-Haloperidol
Drug: Haloperidol-Placebo

First Posted Date: 2001-01-24

Last Posted Date: 2016-05-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 44

Registration Number: NCT00009217

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)

Not Applicable

Completed

Conditions: Seasonal Affective Disorder
Mood Disorders
Depression

Interventions: Device: bright light box
Device: high-output negative ion generator
Device: low-output negative ion generator
Device: dawn simulator
Device: dawn light pulse

First Posted Date: 2000-11-23

Last Posted Date: 2015-06-03

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 150

Registration Number: NCT00006517

Locations: 🇺🇸
Columbia Presbyterian Medical Center, New York, New York, United States

Clinical Trials of Two Non-drug Treatments for Chronic Depression

Not Applicable

Completed

Conditions: Mood Disorders
Depressive Disorders
Depression
Chronic Depression

Interventions: Device: Low-output negative ion generator
Device: High-output negative ion generator
Device: Bright light box

First Posted Date: 2000-08-14

Last Posted Date: 2014-10-01

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 32

Registration Number: NCT00006172

Locations: 🇺🇸
Department of Psychology, Wesleyan University, Middletown, Connecticut, United States
🇺🇸
Columbia Presbyterian Medical Center, New York, New York, United States

Treatment of Panic Disorder: Long Term Strategies

Phase 3

Completed

Conditions: Panic Disorder
Agoraphobia

First Posted Date: 1999-11-03

Last Posted Date: 2014-03-18

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 379

Registration Number: NCT00000368

Locations: 🇺🇸
University of Pittsburgh, Department of Psychiatry, Panic, Anxiety and Traumatic Grief Program, Pittsburgh, Pennsylvania, United States
🇺🇸
Hillside Hospital Phobia Clinic, New York, New York, United States
🇺🇸
Yale University, Department of Psychiatry, Anxiety Disorders Research Clinic, New Haven, Connecticut, United States

and more 1 locations

Antidepressant Treatment of Melancholia in Late Life

Phase 4

Completed

Conditions: Depression
Melancholia

Interventions: Drug: Sertraline
Drug: Nortriptyline

First Posted Date: 1999-11-03

Last Posted Date: 2015-10-07

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 110

Registration Number: NCT00000378

Locations: 🇺🇸
1051 Riverside Drive, New York, New York, United States

New Approaches to Cocaine Abuse Medications (A) - 6

Phase 2

Completed

Conditions: Cocaine-Related Disorders
Substance-Related Disorders

Interventions: Drug: Placebo
Drug: Desipramine

First Posted Date: 1999-09-21

Last Posted Date: 2017-07-05

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 111

Registration Number: NCT00000271

Locations: 🇺🇸
Research Foundation for Mental Hygiene, New York, New York, United States

A Laboratory Model for Heroin Abuse Medications - 8

Phase 2

Completed

Conditions: Opioid-Related Disorders
Substance-Related Disorders
Heroin Dependence

Interventions: Drug: opiates

First Posted Date: 1999-09-21

Last Posted Date: 2017-07-05

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 8

Registration Number: NCT00000273

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
🇺🇸
Columbia University, New York, New York, United States

Brain Imaging: Cocaine Effects & Medication Development - 5

Phase 4

Withdrawn

Conditions: Cocaine-Related Disorders

First Posted Date: 1999-09-21

Last Posted Date: 2017-08-02

Lead Sponsor: New York State Psychiatric Institute

Registration Number: NCT00000270

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

IV Cocaine Abuse: A Laboratory Model - 2

Phase 2

Completed

Conditions: Cocaine-Related Disorders

First Posted Date: 1999-09-21

Last Posted Date: 2015-08-28

Lead Sponsor: New York State Psychiatric Institute

Registration Number: NCT00000213

Locations: 🇺🇸
Columbia University, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy